Vianco Pharma P Ltd
About Vianco Pharma P Ltd
Data last updated:
Vianco Pharma P Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the real estate leasing and property management segment of the real estate sector. It was incorporated on 25 January 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1994PTC076247. Its GSTIN is 27AAACV5173C1ZH (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vikram Kantilal Shah (Managing Director) and Veena Vikram Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6 – D1 Court Chambers 35 Dge Rd.New Marine Lines, Mumbai, Maharashtra, India – 400020.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.64 Lakh. For the same year it recorded a net loss of ₹1.23 Lakh (net margin -12.8%) and EBITDA of -₹1.14 Lakh (EBITDA margin -11.8%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address6 – D1 Court Chambers 35 Dge Rd.New Marine Lines, Mumbai, Maharashtra, India – 400020
- IndustryReal Estate, Real Estate Leasing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Vianco Pharma P Ltd
The main business activity of Vianco Pharma P is real estate activities. In detail, this covers real estate activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| L | Real estate activities | 68 | Real estate activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vianco Pharma P Ltd FY 2025 filings available
Vianco Pharma P Ltd reported revenue of ₹9.64 Lakh for FY 2024.
Compounded Annual Growth Rate (CAGR) of Vianco Pharma P Ltd
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years. EBITDA fell 754% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Vianco Pharma P Ltd
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.14 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.23 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Vianco Pharma P Ltd
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -11.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -12.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vianco Pharma P are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Vianco Pharma P Ltd
Vianco Pharma P Ltd is compared with the companies closest to it by revenue in the same principal business activity (Real estate activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zing India Commercial Private Limited | ₹9.67 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Kolkata, West Bengal, India |
| Proline Buildcon Private Limited | ₹9.66 Lakh (FY 2025) | •••• | •••• | 378.0% | •••• | Thane, Maharashtra, India |
| Nasa Estate Private Limited | ₹9.65 Lakh (FY 2025) | •••• | •••• | 37.0% | •••• | New Delhi, Delhi, India |
| Veros Securities Private Limited | ₹9.65 Lakh (FY 2025) | •••• | •••• | -32.0% | •••• | Kolkata, West Bengal, India |
| Satabdi Udyog Private Limited | ₹9.64 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Kolkata, West Bengal, India |
| Vianco Pharma P Ltd this company | ₹9.64 Lakh (FY 2024) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Propertyshop India Private Limited | ₹9.62 Lakh (FY 2025) | •••• | •••• | 333.0% | •••• | Mumbai, Maharashtra, India |
| Prrashar Kamra Realtors Private Limited | ₹9.6 Lakh (FY 2025) | •••• | •••• | -29.0% | •••• | Mumbai, Maharashtra, India |
| Mithua Developments Pvt Ltd | ₹9.6 Lakh (FY 2025) | •••• | •••• | -16.0% | •••• | Kolkata, West Bengal, India |
| Riconia Estates Private Limited | ₹9.6 Lakh (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Jhavar and Mehta Estates Private Limited | ₹9.6 Lakh (FY 2025) | •••• | •••• | 45.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Vianco Pharma P by revenue in the same principal business activity (Real estate activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Vianco Pharma P Ltd
Vianco Pharma P Ltd is audited by NITISHNIGAM&CO for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NITISHNIGAM&CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Vianco Pharma P Ltd
Vianco Pharma P has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Veena Vikram Shah | Director | 25 Jan 1994 | 32 Years 8 Months | Current |
| Vikram Kantilal Shah Also directs: Sixth Generation Finance and Investment Private Limited | Managing Director | 25 Jan 1994 | 32 Years 8 Months | Current |
| Vivek Vikram Shah Also directs: Cutting Crew Films LLP, Yuvee Legacy LLP | Director | 17 Aug 1999 | 27 Years 1 Months | Current |
| Nehal Vikram Shah | Director | 17 Aug 1999 | 27 Years 1 Months | Current |
Ownership and Shareholding of Vianco Pharma P Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vianco Pharma P Ltd
Vianco Pharma P Ltd does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Vianco Pharma P Ltd
Employment history and EPFO contributions of people linked to Vianco Pharma P.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Vianco Pharma P Ltd
Vianco Pharma P Ltd has 4 board changes on record since 1994: 4 appointments. The latest: Nehal Vikram Shah was appointed as Director on 17 Aug 1999.
Credit Ratings, Litigation & Regulatory Alerts for Vianco Pharma P Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vianco Pharma P Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vianco Pharma P Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vianco Pharma P Ltd
Vianco Pharma P has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACV5173C1ZH | Maharashtra | Active | 01 Apr 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vianco Pharma P Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vianco Pharma P Ltd
Vianco Pharma P is an active private limited company based in Mumbai, Maharashtra, India. The company works in real estate leasing, within the real estate industry. It was incorporated on 25 January 1994 (32+ years old) and is registered under CIN U24230MH1994PTC076247.
Vianco Pharma P reported revenue of ₹9.64 Lakh for FY 2024.
Vianco Pharma P has 4 current directors:
- Vikram Kantilal Shah - Managing Director
- Veena Vikram Shah - Director
- Vivek Vikram Shah - Director
- Nehal Vikram Shah - Director
Vianco Pharma P reported a net loss of ₹1.23 Lakh (net margin -12.8%) and EBITDA of -₹1.14 Lakh (EBITDA margin -11.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Vianco Pharma P is -16% over three years and 1% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Vianco Pharma P is 27AAACV5173C1ZH, registered in Maharashtra.
The CIN (Corporate Identification Number) of Vianco Pharma P is U24230MH1994PTC076247. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vianco Pharma P was incorporated on 25 January 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Vianco Pharma P by revenue are Zing India Commercial Private Limited, Proline Buildcon Private Limited, Nasa Estate Private Limited, Veros Securities Private Limited, Satabdi Udyog Private Limited and 5 more, all in the same principal business activity (Real estate activities).
Nehal Vikram Shah was appointed as Director on 17 Aug 1999. Vivek Vikram Shah was appointed as Director on 17 Aug 1999. Veena Vikram Shah was appointed as Director on 25 Jan 1994. Vianco Pharma P has 4 board changes on record in total.
The registered office of Vianco Pharma P is at 6 – D1 Court Chambers 35 Dge Rd.New Marine Lines, Mumbai, Maharashtra, India – 400020.